Related Experiment Videos
Imaging and radiological intervention in hepatocellular carcinoma
1Department of Diagnostic Radiology, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|March 1, 1997
Summary
Hepatocellular carcinoma (HCC) is a major cause of cancer death in Hong Kong. Imaging and interventional radiology offer options for diagnosing and treating inoperable HCC, impacting patient prognosis.
Area of Science:
- Hepatobiliary oncology
- Diagnostic imaging
- Interventional radiology
Background:
- Hepatocellular carcinoma (HCC) is the second leading cause of cancer mortality in Hong Kong.
- Patient prognosis is significantly influenced by hepatic function, tumor size, and stage at diagnosis.
Purpose of the Study:
- To review the diagnostic utility of various imaging modalities for HCC.
- To discuss the indications and efficacy of interventional radiological treatments for inoperable HCC.
Main Methods:
- Review of imaging techniques including ultrasound, CT, Lipiodal CT, angiography, and MRI.
- Discussion of interventional therapies: transcatheter arterial chemoembolization (TACE), selective internal radiation therapy (SIRT), and percutaneous transhepatic ethanol injection (PTEI).
Main Results:
- Multiple imaging modalities are effective for HCC diagnosis and operability assessment.
- Interventional techniques like TACE, SIRT, and PTEI show promise for managing inoperable HCC.
Conclusions:
- Accurate diagnosis and staging are crucial for HCC patient management.
- Interventional radiology provides valuable treatment options for patients with inoperable hepatocellular carcinoma.